Literature DB >> 29056

Hereditary male pseudohermaphroditism associated with an unstable form of 5 alpha-reductase.

M Leshin, J E Griffin, J D Wilson.   

Abstract

The properties of 5alpha-reductase have been compared in genital skin fibroblasts cultured from five patients from three families (Los Angeles, Dallas, and Dominican Republic) in which hereditary male pseudohermaphroditism has been established to result from deficient conversion of testosterone to dihydrotestosterone. Despite the fact that 5alpha-reductase was immeasurable in a homogenate of epididymis removed from one of the Los Angeles patients, 5alpha-reductase activity was normal in intact fibroblasts and fibroblast extracts from both patients from the Los Angeles family. Although the apparent K(m) for testosterone was also near normal, the apparent K(m) for NADPH in these mutants is elevated some 40-fold above normal. Furthermore, the enzyme is not protected against denaturation at 45 degrees C by concentrations of NADPH that stabilize normal 5alpha-reductase, and in intact fibroblasts from these patients (but not from controls), enzyme activity decreases promptly when protein synthesis is inhibited. We conclude that the mutation in this family results in an unstable enzyme. In contrast 5alpha-reductase activity in fibroblast extracts from a patient from the Dominican Republic family is similar to that previously described in two members of the Dallas family, namely total enzyme activity is low at the optimal pH for the normal reaction, and the apparent K(m) for testosterone is some 20-fold higher than that of the controls. We conclude that the mutations in the Dallas and Dominican Republic families are similar and result in low activity of the enzyme as the result of a decreased affinity for testosterone.Thus, two distinct types of mutations can produce male pseudohermaphroditism due to deficient dihydrotestosterone formation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29056      PMCID: PMC371815          DOI: 10.1172/JCI109176

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Genetic aspects in male hypogonadism.

Authors:  H NOWAKOWSKI; W LENZ
Journal:  Recent Prog Horm Res       Date:  1961

2.  The role of fetal hormones in prenatal development.

Authors:  A JOST
Journal:  Harvey Lect       Date:  1961

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Diminished 5alpha-reductase activity in extracts of fibroblasts cultured from patients with familial incomplete male pseudohermaphroditism, type 2.

Authors:  R J Moore; J E Griffin; J D Wilson
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

Review 5.  Sexual differentiation.

Authors:  J D Wilson
Journal:  Annu Rev Physiol       Date:  1978       Impact factor: 19.318

6.  Characterization of leukocyte glucose 6-phosphate dehydrogenase in Sardinian mutants.

Authors:  A Bonsignore; G Fornaini; G Leoncini; A Fantoni; P Segni
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

7.  The measurement of triphosphopyridine nucleotide and reduced triphosphopyridine nucleotide and the role of hemoglobin in producing erroneous triphosphopyridine nucleotide values.

Authors:  H B Burch; M E Bradley; O H Lowry
Journal:  J Biol Chem       Date:  1967-10-10       Impact factor: 5.157

8.  Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance.

Authors:  J E Griffin; K Punyashthiti; J D Wilson
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

9.  Dihydrotestosterone formation in cultured human fibroblasts. Comparison of cells from normal subjects and patients with familial incomplete male pseudohermaphroditism, Type 2.

Authors:  J D Wilson
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

10.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

View more
  17 in total

1.  A mission statement for the JCI at the dawn of the 21st century.

Authors:  Andrew R Marks
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome.

Authors:  H Klocker; F Kaspar; J Eberle; S Uberreiter; C Radmayr; G Bartsch
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

3.  Intracellular and nuclear binding of [3H]dihydrotestosterone in cultured genital skin fibroblasts of patients with severe hypospadias.

Authors:  H U Schweikert; M Schlüter; G Romalo
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  [Hormonal principles in normal and pathologic somatic sexual development].

Authors:  H U Schweikert; F Neumann
Journal:  Klin Wochenschr       Date:  1986-01-15

5.  Comments on some genetic abnormalities of sex determination and sex differentiation in Homo sapiens.

Authors:  J M Opitz
Journal:  Eur J Pediatr       Date:  1980-03       Impact factor: 3.183

6.  Molecular genetics of steroid 5 alpha-reductase 2 deficiency.

Authors:  A E Thigpen; D L Davis; A Milatovich; B B Mendonca; J Imperato-McGinley; J E Griffin; U Francke; J D Wilson; D W Russell
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 7.  The androgen resistance syndromes: clinical and biochemical aspects.

Authors:  H U Schweikert
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

8.  A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance.

Authors:  M Marcelli; W D Tilley; C M Wilson; J D Wilson; J E Griffin; M J McPhaul
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

9.  Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase.

Authors:  F W George; D W Russell; J D Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  Decrease in androgen binding and effect of androgen treatment in a case of X-linked bulbospinal neuronopathy.

Authors:  A Danek; T N Witt; K Mann; H U Schweikert; G Romalo; A R La Spada; K H Fischbeck
Journal:  Clin Investig       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.